| Andaleeb Rahman, MD | |
|
12255 Fair Lakes Pkwy, Fairfax, VA 22033-3952 | |
| (703) 359-7878 | |
| Not Available |
| Full Name | Andaleeb Rahman |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 12255 Fair Lakes Pkwy, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013367564 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0116029221 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.
Shire plc, the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana® (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).
The Methodist DeBakey Heart & Vascular Center recently received a generous gift to develop a national training center for surgical and interventional treatments for cardiovascular disease, the number one killer of Americans. The benefactor wishes to remain anonymous.
The New York Times reports that some states are scrambling to ensure they can comply with the new federal health law. "Insurance commissioners in about half the states say they do not have clear authority to enforce consumer protection standards that take effect next month. Federal and state officials are searching for ways to plug the gap. Otherwise, they say, the ability of consumers to secure the benefits of the new law could vary widely, depending on where they live."
Peregrine Pharmaceuticals has announced it has filed a new clinical trial protocol with the FDA to study bavituximab in patients co-infected with HCV and the human immunodeficiency virus (HIV).
› Verified 2 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.
Shire plc, the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana® (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).
The Methodist DeBakey Heart & Vascular Center recently received a generous gift to develop a national training center for surgical and interventional treatments for cardiovascular disease, the number one killer of Americans. The benefactor wishes to remain anonymous.
The New York Times reports that some states are scrambling to ensure they can comply with the new federal health law. "Insurance commissioners in about half the states say they do not have clear authority to enforce consumer protection standards that take effect next month. Federal and state officials are searching for ways to plug the gap. Otherwise, they say, the ability of consumers to secure the benefits of the new law could vary widely, depending on where they live."
Peregrine Pharmaceuticals has announced it has filed a new clinical trial protocol with the FDA to study bavituximab in patients co-infected with HCV and the human immunodeficiency virus (HIV).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andaleeb Rahman, MD 12255 Fair Lakes Pkwy, Fairfax, VA 22033-3952 Ph: (703) 359-7878 | Andaleeb Rahman, MD 12255 Fair Lakes Pkwy, Fairfax, VA 22033-3952 Ph: (703) 359-7878 |
News Archive
The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.
Shire plc, the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana® (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).
The Methodist DeBakey Heart & Vascular Center recently received a generous gift to develop a national training center for surgical and interventional treatments for cardiovascular disease, the number one killer of Americans. The benefactor wishes to remain anonymous.
The New York Times reports that some states are scrambling to ensure they can comply with the new federal health law. "Insurance commissioners in about half the states say they do not have clear authority to enforce consumer protection standards that take effect next month. Federal and state officials are searching for ways to plug the gap. Otherwise, they say, the ability of consumers to secure the benefits of the new law could vary widely, depending on where they live."
Peregrine Pharmaceuticals has announced it has filed a new clinical trial protocol with the FDA to study bavituximab in patients co-infected with HCV and the human immunodeficiency virus (HIV).
› Verified 2 days ago
Thuy Phuong Thi Vo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3650 Joseph Siewick Dr, 400, Fairfax, VA 22033 Phone: 703-391-2020 | |
Dr. David Drake Leonard, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3911 Blenheim Blvd Ste 41c, Fairfax, VA 22030 Phone: 703-352-7100 Fax: 703-539-8579 | |
Dr. Sally May Abilmona, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3650 Joseph Siewick Dr Ste 400, Fairfax, VA 22033 Phone: 703-391-2020 | |
Hannah Byrd Depoy, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3650 Joseph Siewick Dr, Fairfax, VA 22033 Phone: 703-391-2020 | |
Dr. Heon Soo Yi, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3650 Joseph Siewick Dr, Suite 400, Fairfax, VA 22033 Phone: 703-391-2020 | |
Serena Lian, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3650 Joseph Siewick Dr Ste 400, Fairfax, VA 22033 Phone: 703-391-2020 |